Publication date: 8 Dec 2022
Associated community Membranoproliferative Glomerulonephritis (aka Complement 3 Glomerulopathy C3G)
If you have been diagnosed with C3G (Complement 3 Glomerulopathy) or are suspected of having it, a clinical trial may be an option for you. Researchers are looking for volunteers between 18 and 60 years of age to help evaluate an investigational C3G oral drug. C3G is a rare kidney disease, so taking part in research like this has the potential to help people today and advance future research. If you’re interested, click the link below to see if you’re eligible.